E D Ehrenpreis

Summary

Affiliation: University of Chicago
Country: USA

Publications

  1. ncbi Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial
    E D Ehrenpreis
    Department of Gastroenterology, University of Chicago Hospitals, Chicago, IL 60637, USA
    Gastroenterology 117:1271-7. 1999
  2. ncbi Treatment of anal fissures with topical nitroglycerin
    E D Ehrenpreis
    Department of Gastroenterology, University of Chicago Hospitals, 5841 South Maryland Avenue, MC 4076, Chicago, Illinois 60637, USA
    Expert Opin Pharmacother 2:41-5. 2001
  3. ncbi Thalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature
    P M Ginsburg
    Department of Gastroenterology, University of Chicago Hospitals, IL 60637, USA
    Ann Med 33:516-25. 2001
  4. ncbi A pilot study of thalidomide for patients with symptomatic mesenteric panniculitis
    P M Ginsburg
    Division of Gastroenterology, Department of Medicine, University of Chicago Hospitals, Chicago, IL 60637, USA
    Aliment Pharmacol Ther 16:2115-22. 2002
  5. ncbi Review article: current therapeutic options for radiation proctopathy
    J J Hong
    Gastroenterology Division, Department of Medicine, University of Chicago, Pritzker School of Medicine, Chicago, IL 60637, USA
    Aliment Pharmacol Ther 15:1253-62. 2001
  6. ncbi Retrograde endoscopic delivery of botulinum toxin for anal fissures
    T P Kinney
    University of Chicago Medical Center, Chicago, Illinois 60637, USA
    Endoscopy 38:654. 2006
  7. ncbi Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis
    E D Ehrenpreis
    Department of Gastroenterology, Highland Park Hospital, NorthShore University Healthsystem, Highland Park, IL 60035, USA
    Aliment Pharmacol Ther 29:1202-11. 2009

Detail Information

Publications7

  1. ncbi Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial
    E D Ehrenpreis
    Department of Gastroenterology, University of Chicago Hospitals, Chicago, IL 60637, USA
    Gastroenterology 117:1271-7. 1999
    ..Inhibition of tumor necrosis factor is a proposed mechanism for the anti-inflammatory properties of thalidomide. We performed an open-label trial of thalidomide in refractory Crohn's disease...
  2. ncbi Treatment of anal fissures with topical nitroglycerin
    E D Ehrenpreis
    Department of Gastroenterology, University of Chicago Hospitals, 5841 South Maryland Avenue, MC 4076, Chicago, Illinois 60637, USA
    Expert Opin Pharmacother 2:41-5. 2001
    ..This review summarises current literature regarding topical nitroglycerin pharmacotherapy for anal fissure...
  3. ncbi Thalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature
    P M Ginsburg
    Department of Gastroenterology, University of Chicago Hospitals, IL 60637, USA
    Ann Med 33:516-25. 2001
    ..Special attention is directed towards its history, mechanisms, and proposed role. The recent development of thalidomide analogues is also discussed briefly...
  4. ncbi A pilot study of thalidomide for patients with symptomatic mesenteric panniculitis
    P M Ginsburg
    Division of Gastroenterology, Department of Medicine, University of Chicago Hospitals, Chicago, IL 60637, USA
    Aliment Pharmacol Ther 16:2115-22. 2002
    ..There were no serious adverse events. CONCLUSIONS: Thalidomide is safe, well tolerated and efficacious in the treatment of some patients with symptomatic mesenteric panniculitis. Further study is indicated...
  5. ncbi Review article: current therapeutic options for radiation proctopathy
    J J Hong
    Gastroenterology Division, Department of Medicine, University of Chicago, Pritzker School of Medicine, Chicago, IL 60637, USA
    Aliment Pharmacol Ther 15:1253-62. 2001
    ..Given that formal randomized placebo-controlled studies are lacking for most treatments, the management of these patients is often challenging and unclear. Hence, there is a need for more research and education on radiation proctopathy...
  6. ncbi Retrograde endoscopic delivery of botulinum toxin for anal fissures
    T P Kinney
    University of Chicago Medical Center, Chicago, Illinois 60637, USA
    Endoscopy 38:654. 2006
  7. ncbi Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis
    E D Ehrenpreis
    Department of Gastroenterology, Highland Park Hospital, NorthShore University Healthsystem, Highland Park, IL 60035, USA
    Aliment Pharmacol Ther 29:1202-11. 2009
    ..Sodium phosphate containing colonoscopy preparations may cause electrolyte disturbances and calcium-phosphate nephropathy. Decreased body weight is an unexplored risk factor for complications with sodium phosphate ingestion...